Repaglinide restrains HCC development and progression by targeting FOXO3/lumican/p53 axis
Article in Cellular Oncology (February 2024)
The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.
Article in Cellular Oncology (February 2024)
Article in Oncology Letters (October 2021)
Article in Journal of Gastroenterology and Hepatology (August 2021)